Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study.

Détails

Ressource 1Télécharger: 35564733_BIB_9A80E8D0D202.pdf (663.53 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_9A80E8D0D202
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study.
Périodique
International journal of environmental research and public health
Auteur⸱e⸱s
Gerbier E., Favre G., Tauqeer F., Winterfeld U., Stojanov M., Oliver A., Passier A., Nordeng H., Pomar L., Baud D., Panchaud A., Meyer-Massetti C., Ceulemans M.
ISSN
1660-4601 (Electronic)
ISSN-L
1660-4601
Statut éditorial
Publié
Date de publication
27/04/2022
Peer-reviewed
Oui
Volume
19
Numéro
9
Pages
5335
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June-August 2021). An online questionnaire was distributed in five European countries between June-August 2021. Pregnant women or women who had delivered in the three preceding months, and ≥18 years old, could participate. The prevalence of overall medication use, self-medication, and changes in chronic medication use were determined. A total of 2158 women out of 5210 participants (41.4%) used at least one medication. Analgesics (paracetamol), systemic antihistamines (cetirizine), and drugs for gastric disorders (omeprazole) were the three most used classes. Anti-infectives were less prevalent than during pre-pandemic times. Antidepressants and anxiety related medication use remained similar, despite a higher prevalence of these symptoms. Self-medication was reported in 19.4% of women, and 4.1% of chronic medication users reported that they changed a chronic medication on personal initiative due to the pandemic. In conclusion, medication use patterns in our cohort were mostly similar to those of the first COVID-19 wave and the pre-pandemic period. More studies are needed to explore factors associated with self-medication and changes in chronic medication use due to the pandemic in this perinatal population.
Mots-clé
Adolescent, Anxiety/epidemiology, COVID-19/drug therapy, COVID-19/epidemiology, Cross-Sectional Studies, Female, Humans, Pandemics, Parturition, Postpartum Period, Pregnancy, Pregnant Women, Self Report, COVID-19, Europe, chronic disease, drug utilization, medication use, pandemic, pharmacoepidemiology, postpartum, pregnancy, self-medication
Pubmed
Web of science
Open Access
Oui
Création de la notice
23/05/2022 14:12
Dernière modification de la notice
23/01/2024 8:31
Données d'usage